IFLR1000

China Biologic $590 million secondary offering

24/8/2018
Private placement of shares
Select tab

$ 590 million

Announced

24/8/2018

Overview:

  • China Biologic has announced the issue of $590 million shares.
  • The shares will be privately placed to Centurium Capital Management, CITIC Capital Holdings, Hillhouse Capital Management and PW Medtech Group.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

China

Deal type:

Private placement of shares

Practice area:

Capital markets : Equity

Governing law:

China

Industry sector:

Pharmaceuticals and life sciences

Firms:
Davis Polk & Wardwell

Party: China Biologic (Issuer)

Lawyer: Howard Zhang

Wilson Sonsini Goodrich & Rosati

Party: CITIC Capital Holdings (Buyer)

Party: PW Medtech Group Ltd (Buyer)

Party: Centurium Capital Management (Buyer)

Party: Hillhouse Capital Management (Buyer)

Lawyer: Jie Zhu

Related deals